Signaling lymphocytic activation molecules Slam and cancers: friends or foes?

Signaling Lymphocytic Activation Molecules (SLAM) family receptors are initially described in immune cells. These receptors recruit both activating and inhibitory SH2 domain containing proteins through their Immunoreceptor Tyrosine based Switch Motifs (ITSMs). Accumulating evidence suggest that the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Fouquet, Gregory, Marcq, Ingrid, Debuysscher, Véronique, Bayry, Jagadeesh, Rabbind Singh, Amrathlal, Bengrine, Abderrahmane, Nguyen-Khac, Eric, Naassila, Mickael, Bouhlal, Hicham
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5882332/
https://ncbi.nlm.nih.gov/pubmed/29662641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24575
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados